Breakfast Sessions
About the Breakfast Sessions
Breakfast sessions are available for all delegates to attend (excluding exhibitors) and spaces are limited and strictly on a first come first serve basis. A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence.
Please click on the links below for more information on the breakfast topics. In order to attend the breakfast sessions, you will be required to indicate your attendance as part of your registration form.
Wednesday 14 June
Breakfast session supported by Eisai
Thursday 15 June
Breakfast Session 1 - Supported by Gilead
Breakfast Session 2 - Supported by Lilly
Friday 16 June
Breakfast Session 1 - Supported by AstraZeneca
Breakfast Session 2 - Supported by Bayer
Wednesday 14 June
Title: The evolving role of lenvatinib in combination with pembrolizumab for advanced endometrial cancer and renal cell carcinoma: practical guidance for managing lenvatinib therapy
Time: 0830 - 0930 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (8.00am - 8.30am). This will be served outside the meeting room.
Presenters:
Dr Shirley Wong – Medical Oncologist
The Western Hospital Melbourne
Mr Micheal Cooney - Nurse Practitioner – Oncology/Haematology
Northern Health Melbourne
Description: TBC
Thursday 15 June
Title: Cracking the Case: Do insights lead to better patient management?
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenters:
Justin Hargreaves, Oncology NP, Bendigo Health
Gillian Kruss, MBC NP, Monaash Health & Chief Clinical Lead Education, McGrath Foundation
Michael Fitzgerald, Medical Oncology NP, Flinders Medical Centre
Title: How patient management is going to change with Verzenio (Abemaciclib) for HR+HER2- eBC, building on experience from mBC
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenters:
Description: TBC
Friday 16 June
Title: Practical considerations for nurses treating HER2+ mBC patients with Enhertu (trastuzumb deruxtecan)
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenters:
A/Prof Nick Murray
Ms Katherine Cox (McGrath mBC Nurse Consultant)
Ms Gill Kruss (Nurse Practitioner & McGrath Chief Clinic Lead)
Description:
All three speakers will provide insights into the evolving HER2 mBC landscape and provide practical tips in managing patients being treated with Enhertu (trastuzumb deruxtecan).
Title: The Changing Landscape of Advanced Prostate Cancer
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenter: Dr Vineet Kwatra (MBBS FRACP) Medical Oncologist
Description:
Topics covered:
1) Stages of advanced prostate cancer and what they mean (i.e nmCRPC, mHSPC, mCRPC)
2) Available treatments on the PBS and/or Access programs
3) What to consider when prescribing medications
4) Importance of maintaining QoL and minimising side-effects